Related Experiment Video

Updated: Jul 5, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Helicases as prospective targets for anti-cancer therapy

Rigu Gupta1, Robert M Brosh

  • 1Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA.

Anti-Cancer Agents in Medicinal Chemistry
|May 14, 2008
PubMed

Insights

Targeting DNA repair pathways, specifically DNA helicases, offers a promising strategy to enhance anti-cancer therapies. Modulating helicase function can selectively kill cancer cells by disrupting DNA repair mechanisms crucial for their survival.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA repair pathways are critical for maintaining genomic stability.
  • DNA helicases play vital roles in DNA damage response and repair.
  • Selective inactivation of DNA repair can potentiate anti-cancer treatments.

Purpose of the Study:

  • To review the roles of DNA helicases in DNA repair.
  • To explore helicase functions as targets for cancer therapeutic strategies.
  • To examine how modulating helicase function can enhance cancer treatment efficacy.

Main Methods:

  • Review of scientific literature on DNA helicases and DNA repair.
  • Analysis of the involvement of helicases in DNA recombination and replication restart.
  • Examination of helicase-dependent cell cycle checkpoint roles.

Main Results:

  • DNA helicases are crucial for multiple DNA repair processes.
  • Targeting helicase expression or function can selectively eliminate cancer cells.
  • Modulation of helicases enhances therapies involving DNA damaging agents or radiation.

Conclusions:

  • Helicase-mediated DNA repair pathways are viable targets for novel cancer therapies.
  • Small molecule compounds targeting helicases represent a promising therapeutic approach.
  • Inactivating helicase-dependent repair enhances the efficacy of cytotoxic cancer treatments.

More Related Videos

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Related Concept Videos

DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...